"Antirheumatic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that are used to treat RHEUMATOID ARTHRITIS.
| Descriptor ID |
D018501
|
| MeSH Number(s) |
D27.505.954.329
|
| Concept/Terms |
Antirheumatic Agents- Antirheumatic Agents
- Anti-Rheumatic Drugs
- Anti Rheumatic Drugs
- Antirheumatic Drugs
- Anti-Rheumatic Agents
- Anti Rheumatic Agents
Antirheumatic Drugs, Disease-Modifying- Antirheumatic Drugs, Disease-Modifying
- Antirheumatic Drugs, Disease Modifying
- DMARD
- Disease-Modifying, Antirheumatic Second-Line Drugs
- Disease Modifying, Antirheumatic Second Line Drugs
- Antirheumatic Disease-Modifying Second-Line Drugs
- Antirheumatic Disease Modifying Second Line Drugs
- Disease-Modifying Antirheumatic Drugs
- Disease Modifying Antirheumatic Drugs
|
Below are MeSH descriptors whose meaning is more general than "Antirheumatic Agents".
Below are MeSH descriptors whose meaning is more specific than "Antirheumatic Agents".
This graph shows the total number of publications written about "Antirheumatic Agents" by people in this website by year, and whether "Antirheumatic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 4 | 0 | 4 |
| 2001 | 1 | 0 | 1 |
| 2002 | 3 | 1 | 4 |
| 2003 | 1 | 2 | 3 |
| 2004 | 0 | 1 | 1 |
| 2005 | 4 | 1 | 5 |
| 2006 | 1 | 1 | 2 |
| 2007 | 3 | 1 | 4 |
| 2008 | 4 | 3 | 7 |
| 2009 | 5 | 1 | 6 |
| 2010 | 8 | 2 | 10 |
| 2011 | 5 | 1 | 6 |
| 2012 | 5 | 1 | 6 |
| 2013 | 5 | 2 | 7 |
| 2014 | 4 | 0 | 4 |
| 2015 | 3 | 1 | 4 |
| 2016 | 6 | 4 | 10 |
| 2017 | 9 | 2 | 11 |
| 2018 | 8 | 5 | 13 |
| 2019 | 12 | 1 | 13 |
| 2020 | 7 | 1 | 8 |
| 2021 | 5 | 0 | 5 |
| 2022 | 6 | 0 | 6 |
| 2023 | 11 | 0 | 11 |
| 2024 | 5 | 2 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antirheumatic Agents" by people in Profiles.
-
Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study. J Rheumatol. 2024 Nov 01; 51(11):1125-1134.
-
Trends in the use of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and recently diagnosed colorectal, lung, or prostate cancer. Clin Rheumatol. 2024 Nov; 43(11):3301-3312.
-
Survival in patients with rheumatoid arthritis and early breast cancer treated with tumor necrosis factor inhibitors. Breast Cancer. 2024 Nov; 31(6):1059-1070.
-
Interleukin-6 receptor antagonists in pregnancy: a reason for cautious optimism. Lancet Rheumatol. 2024 Sep; 6(9):e592-e593.
-
Methotrexate: Borrowed Hope for Persons With Knee Osteoarthritis? Ann Intern Med. 2024 Sep; 177(9):1271-1272.
-
A narrative review of the comparative safety of disease-modifying anti-rheumatic drugs used for the treatment of rheumatoid arthritis. Expert Opin Drug Saf. 2024 Jun; 23(6):687-714.
-
Utilization of Biologic Disease-Modifying Antirheumatic Therapy in Patients With Rheumatoid Arthritis and Recently Diagnosed Breast Cancer. Arthritis Care Res (Hoboken). 2024 06; 76(6):850-859.
-
How to Use Janus Kinase Inhibitors in the Treatment of Rheumatoid Arthritis? A Clinical Assessment of Risks and Benefits. Curr Rheumatol Rep. 2023 12; 25(12):295-306.
-
Real-world Comparative Effectiveness of Methotrexate-based Combinations for Rheumatoid Arthritis: A Retrospective Cohort Study. Clin Ther. 2023 09; 45(9):e177-e186.
-
Risk of incident cardiovascular events with disease-modifying anti-rheumatic drugs among adults with rheumatoid arthritis: a nested case-control study. Clin Rheumatol. 2024 Jan; 43(1):103-116.